Literature DB >> 21893639

Pediatric polypharmacy: time to lock the medicine cabinet?

Nancy E Morden, David Goodman.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21893639      PMCID： PMC3248612          DOI： 10.1001/archpediatrics.2011.162

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN： 1072-4710


× No keyword cloud information.
  12 in total

1.  Storm over statins--the controversy surrounding pharmacologic treatment of children.

Authors:  Sarah de Ferranti; David S Ludwig
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

2.  Medication errors and adverse drug events in pediatric inpatients.

Authors:  R Kaushal; D W Bates; C Landrigan; K J McKenna; M D Clapp; F Federico; D A Goldmann
Journal:  JAMA       Date:  2001-04-25       Impact factor: 56.272

Review 3.  Drug-related problems in hospitals: a review of the recent literature.

Authors:  Anita Krähenbühl-Melcher; Raymond Schlienger; Markus Lampert; Manuel Haschke; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Variation in receipt of opioids by pediatric oncology patients who died in children's hospitals.

Authors:  Andrea D Orsey; Jean B Belasco; Jonas H Ellenberg; Kathryn H Schmitz; Chris Feudtner
Journal:  Pediatr Blood Cancer       Date:  2009-07       Impact factor: 3.167

5.  Inappropriate use of antibiotics for acute asthma in United States emergency departments.

Authors:  Stefan G Vanderweil; Chu-Lin Tsai; Andrea J Pelletier; Janice A Espinola; Ashley F Sullivan; David Blumenthal; Carlos A Camargo
Journal:  Acad Emerg Med       Date:  2008-07-08       Impact factor: 3.451

Review 6.  Current status of pain management in children.

Authors:  Richard F Howard
Journal:  JAMA       Date:  2003-11-12       Impact factor: 56.272

Review 7.  Long-term consequences of drugs on the paediatric cardiovascular system.

Authors:  Elizabeth Hausner; Monica L Fiszman; Joseph Hanig; Patricia Harlow; Gwen Zornberg; Solomon Sobel
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial.

Authors:  Martin C J Kneyber; Job B M van Woensel; Esther Uijtendaal; Cuno S P M Uiterwaal; Jan L L Kimpen
Journal:  Pediatr Pulmonol       Date:  2008-02

9.  Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.

Authors:  Desireé L Kunac; Julia Kennedy; Nicola Austin; David Reith
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

10.  The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial.

Authors:  Marieke J J Ermers; Maroeska M Rovers; Job B van Woensel; Jan L L Kimpen; Louis J Bont
Journal:  BMJ       Date:  2009-03-31
View more
  5 in total

1.  Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists.

Authors:  Marcia A Kearns; Kristin M Hawley
Journal:  J Psychiatr Pract       Date:  2014-11       Impact factor: 1.325

2.  Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.

Authors:  Drew E Winters; Sadaaki Fukui; Ellen Leibenluft; Leslie A Hulvershorn
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-04-30       Impact factor: 2.576

3.  Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study.

Authors:  Niccolò Lombardi; Giada Crescioli; Alessandra Bettiol; Ettore Marconi; Antonio Vitiello; Roberto Bonaiuti; Anna Maria Calvani; Stefano Masi; Ersilia Lucenteforte; Alessandro Mugelli; Lisa Giovannelli; Alfredo Vannacci
Journal:  BMC Pharmacol Toxicol       Date:  2018-04-16       Impact factor: 2.483

4.  Prescribing patterns of polypharmacy in Korean pediatric patients.

Authors:  Soo-Min Jeon; Susan Park; Sandy Jeong Rhie; Jin-Won Kwon
Journal:  PLoS One       Date:  2019-10-01       Impact factor: 3.240

Review 5.  Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis.

Authors:  Jackline Joy Martín Lasola; Henry Kamdem; Michael W McDaniel; Ryan M Pearson
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.